These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1137 related items for PubMed ID: 11337363
1. Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse. Hong SW, Isono M, Chen S, Iglesias-De La Cruz MC, Han DC, Ziyadeh FN. Am J Pathol; 2001 May; 158(5):1653-63. PubMed ID: 11337363 [Abstract] [Full Text] [Related]
2. Smad pathway is activated in the diabetic mouse kidney and Smad3 mediates TGF-beta-induced fibronectin in mesangial cells. Isono M, Chen S, Hong SW, Iglesias-de la Cruz MC, Ziyadeh FN. Biochem Biophys Res Commun; 2002 Sep 06; 296(5):1356-65. PubMed ID: 12207925 [Abstract] [Full Text] [Related]
3. Heterozygous mice for TGF-betaIIR gene are resistant to the progression of streptozotocin-induced diabetic nephropathy. Kim HW, Kim BC, Song CY, Kim JH, Hong HK, Lee HS. Kidney Int; 2004 Nov 06; 66(5):1859-65. PubMed ID: 15496156 [Abstract] [Full Text] [Related]
4. Leptin stimulates type I collagen production in db/db mesangial cells: glucose uptake and TGF-beta type II receptor expression. Han DC, Isono M, Chen S, Casaretto A, Hong SW, Wolf G, Ziyadeh FN. Kidney Int; 2001 Apr 06; 59(4):1315-23. PubMed ID: 11260392 [Abstract] [Full Text] [Related]
5. Effects of Chinese traditional compound, JinSanE, on expression of TGF-beta1 and TGF-beta1 type II receptor mRNA, Smad3 and Smad7 on experimental hepatic fibrosis in vivo. Song SL, Gong ZJ, Zhang QR, Huang TX. World J Gastroenterol; 2005 Apr 21; 11(15):2269-76. PubMed ID: 15818738 [Abstract] [Full Text] [Related]
6. Activation of the TGF-beta/Smad signaling pathway in focal segmental glomerulosclerosis. Kim JH, Kim BK, Moon KC, Hong HK, Lee HS. Kidney Int; 2003 Nov 21; 64(5):1715-21. PubMed ID: 14531804 [Abstract] [Full Text] [Related]
7. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells. Poncelet AC, de Caestecker MP, Schnaper HW. Kidney Int; 1999 Oct 21; 56(4):1354-65. PubMed ID: 10504488 [Abstract] [Full Text] [Related]
8. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition. Yang J, Dai C, Liu Y. J Am Soc Nephrol; 2005 Jan 21; 16(1):68-78. PubMed ID: 15537870 [Abstract] [Full Text] [Related]
9. Oxidized LDL activates PAI-1 transcription through autocrine activation of TGF-beta signaling in mesangial cells. Song CY, Kim BC, Hong HK, Lee HS. Kidney Int; 2005 May 21; 67(5):1743-52. PubMed ID: 15840021 [Abstract] [Full Text] [Related]
10. Transforming growth factor-β1-mediated renal fibrosis is dependent on the regulation of transforming growth factor receptor 1 expression by let-7b. Wang B, Jha JC, Hagiwara S, McClelland AD, Jandeleit-Dahm K, Thomas MC, Cooper ME, Kantharidis P. Kidney Int; 2014 Feb 21; 85(2):352-61. PubMed ID: 24088962 [Abstract] [Full Text] [Related]
12. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. Ziyadeh FN, Hoffman BB, Han DC, Iglesias-De La Cruz MC, Hong SW, Isono M, Chen S, McGowan TA, Sharma K. Proc Natl Acad Sci U S A; 2000 Jul 05; 97(14):8015-20. PubMed ID: 10859350 [Abstract] [Full Text] [Related]